✦ LIBER ✦

Percutaneous portal-systemic shunts: Promise and problems

✍ Scribed by David S. Zimmon

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 285 KB
Volume: 8
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840080349

No coin nor oath required. For personal study only.

✦ Synopsis

A randomised controlled trial with human lymphoblastoid interferon vs no treatment in chronic hepatitis B virus infection. J Hepatol 1986; 3:5235-S238. 5. Dusheiko G, Dibisceglie, Bowyer S, et al. Recombinant leukocyte interferon treatment of chronic hepatitis B. Hepatology 1985; 6. Scully U, Shein P, Karayiannis JA, et al. Lymphoblastoid interferon therapy of chronic HBV infection-A comparison of 12 vs 24 weeks of thrice weekly treatment.

📜 SIMILAR VOLUMES

Portal-systemic shunts for Budd-Chiari s

Portal-systemic shunts for Budd-Chiari syndrome

✍ Marshall J. Orloff 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Portal-systemic shunting and portal-syst

Portal-systemic shunting and portal-systemic encephalopathy: A predictable relationship

✍ Professor of Medicine Harold O. Conn 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB

## Objective Results of the first prospective randomized clinical trial comparing partial and total portacaval shunt for variceal hemorrhage are reported. Summary Background Data Total portacaval shunts produce subnormal portal pressures, completely diverting hepatic portal flow. Partial shunts ma

Selection of portal-systemic shunts with

Selection of portal-systemic shunts with an eye to subsequent liver transplantation

✍ M. Wayne Flye 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

Distal splenorenal vs. portal-systemic s

Distal splenorenal vs. portal-systemic shunts after hemorrhage from varices: A randomized controlled trial

✍ Norman D. Grace; Harold O. Conn; Robert H. Resnick; Roberto J. Groszmann; Colin 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 812 KB

Between 1975 and 1983, 303 cirrhotic patients with endoscopically proven major variceal hemorrhage were admitted to the participating hospitals of the Boston-New Haven Collaborative Liver Group. Of these, 274 were evaluated for admission to a prospective, randomized controlled trial comparing porta

High prevalence of spontaneous portal-sy

High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: A case-control study

✍ Oliviero Riggio; Cesare Efrati; Carlo Catalano; Federica Pediconi; Oriano Mecare 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

Large spontaneous portal-systemic shunts have been occasionally described in patients with cirrhosis. This study was undertaken to assess the prevalence of portal-systemic shunts in patients with cirrhosis with recurrent or persistent hepatic encephalopathy (HE) as compared with patients with cirrho

Acetylsalicylic acid in the prevention o

Acetylsalicylic acid in the prevention of early stenosis and occlusion of transjugular intrahepatic portal-systemic stent shunts: A controlled study

✍ Dr. Lorenz Theilmann; Peter Sauer; Thomas Roeren; Gerd Otto; Joachim C. Arnold; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 611 KB

Stenosis or occlusion of the transjugular intrahepatic portal-systemic stent shunt may be initiated by aggregation and activation of thrombocytes on the surface of the metallic stent material. To find effective prevention of this event, we conducted a controlled trial administering acetylsalicylic a